Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 246 clinical trials
  • None views
  • None views
  • None views
  • None views
Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.

Efficacy and Safety of Locoregional treatments Combined With PD-1 Inhibitor in Patients With Unresectable Hepatocellular Carcinoma.

carcinoma
TACE
sintilimab
unresectable hepatocellular carcinoma
microwave ablation
  • 0 views
  • 16 Feb, 2024
  • 1 location
Preliminary Antitumor Activity Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma

The primary objective of this study is to assess the preliminary antitumor activity as indicated by overall response rate (ORR) of tislelizumab in combination with lenvatinib in participants with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).

carcinoma
unresectable hepatocellular carcinoma
hepatocellular carcinoma metastatic
metastatic hepatocellular carcinoma
hepatocellular carcinoma
  • 0 views
  • 05 Aug, 2020